1. Highly efficient prevention of radiation dermatitis using a PEGylated superoxide dismutase dissolving microneedle patch.
- Author
-
Ma Z, Chen Y, Tang K, Yang H, Tian M, Xi X, Han S, Yang S, Ru L, and Yu X
- Subjects
- Animals, Mice, Male, Radiation-Protective Agents administration & dosage, Radiation-Protective Agents pharmacology, Radiation-Protective Agents pharmacokinetics, Polyethylene Glycols chemistry, Superoxide Dismutase metabolism, Superoxide Dismutase administration & dosage, Needles, Skin metabolism, Skin drug effects, Skin radiation effects, Administration, Cutaneous, Radiodermatitis prevention & control, Transdermal Patch, Skin Absorption drug effects
- Abstract
PEGylated superoxide dismutase (PEG-SOD) is commonly used as a cytoprotective agent in radiotherapy. However, its effectiveness in preventing radiation dermatitis is limited owing to its poor skin permeability. To address this issue, a PEG-SOD-loaded dissolving microneedle (PSMN) patch was developed to effectively prevent radiation dermatitis. Initially, PSMN patches were fabricated using a template mold method with polyvinylpyrrolidone K90 as the matrix material. PSMNs exhibited a conical shape with adequate mechanical strength to penetrate the stratum corneum. More than 90 % of PEG-SOD was released from the PSMN patches within 30 min. Notably, the PSMN patches showed a significantly higher drug skin permeation than the PEG-SOD solutions, with a 500-fold increase. In silico simulations and experiments on skin pharmacokinetics confirmed that PSMN patches enhanced drug permeation and skin absorption, in contrast to PEG-SOD solutions. More importantly, PSMN patches efficiently mitigated ionizing radiation-induced skin damage, accelerated the healing process of radiation-affected skin tissues, and exhibited highly effective radioprotective activity for DNA in the skin tissue. Therefore, PSMN patches are promising topical remedy for the prevention of radiation dermatitis., Competing Interests: Declaration of Competing Interest The authors declared no conflicts of interest regarding this study., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF